Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/subset-of-suz12-prc2-target-genes-is-activated-during-hepatitis-b-ugGRXw8aYv
References (54)
-
J. Bruix, L. Boix, M. Sala, J. Llovet (2004)
Focus on hepatocellular carcinoma.Cancer cell, 5 3
-
C. Madden, M. Finegold, B. Slagle (2001)
Hepatitis B Virus X Protein Acts as a Tumor Promoter in Development of Diethylnitrosamine-Induced Preneoplastic LesionsJournal of Virology, 75
-
Christian Gocke, Hongtao Yu (2008)
ZNF198 Stabilizes the LSD1–CoREST–HDAC1 Complex on Chromatin through Its MYM-Type Zinc FingersPLoS ONE, 3
-
S. Squazzo, H. O’Geen, Vitalina Komashko, S. Krig, V. Jin, S. Jang, R. Margueron, D. Reinberg, Roland Green, P. Farnham (2006)
Suz12 binds to silenced regions of the genome in a cell-type-specific manner.Genome research, 16 7
-
Llovet (2008)
Sorafenib in advanced hepatocellular carcinomaN Engl J Med, 359
-
Wen‐Horng Wang, R. Hullinger, O. Andrisani (2008)
Hepatitis B Virus X Protein via the p38MAPK Pathway Induces E2F1 Release and ATR Kinase Activation Mediating p53 Apoptosis*Journal of Biological Chemistry, 283
-
Tao Li, Ji-fan Hu, X. Qiu, J. Ling, Huiling Chen, Shukui Wang, Aiju Hou, T. Vu, A. Hoffman (2008)
CTCF Regulates Allelic Expression of Igf2 by Orchestrating a Promoter-Polycomb Repressive Complex 2 Intrachromosomal LoopMolecular and Cellular Biology, 28
-
(2010)
Hepatitis B virus X protein activates Polo-like Kinase-1 inducing checkpoint adaptation, suppression of DNA repair and p53 apoptosis -
S. Toffanin, Y. Hoshida, A. Lachenmayer, A. Villanueva, L. Cabellos, B. Mínguez, R. Savić, S. Ward, S. Thung, Derek Chiang, Clara Alsinet, V. Tovar, S. Roayaie, M. Schwartz, J. Bruix, S. Waxman, S. Friedman, T. Golub, V. Mazzaferro, J. Llovet (2011)
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.Gastroenterology, 140 5
-
P. Moinzadeh, K. Breuhahn, K. Breuhahn, H. Stützer, Peter Schirmacher, Peter Schirmacher (2005)
Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade – results of an explorative CGH meta-analysisBritish Journal of Cancer, 92
-
S. Ladner, M. Otto, C. Barker, K. Zaifert, Guang-hua Wang, Ju-Tao Guo, C. Seeger, R. King (1997)
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replicationAntimicrobial Agents and Chemotherapy, 41
-
Miao-Chih Tsai, Ohad Manor, Y. Wan, N. Mosammaparast, Jordon Wang, F. Lan, Yang Shi, E. Segal, Howard Chang (2010)
Long Noncoding RNA as Modular Scaffold of Histone Modification ComplexesScience, 329
-
C. Tarn, M. Bilodeau, R. Hullinger, O. Andrisani (1999)
Differential Immediate Early Gene Expression in Conditional Hepatitis B Virus pX-transforming Versus Nontransforming Hepatocyte Cell Lines*The Journal of Biological Chemistry, 274
-
Leo Studach, Lova Rakotomalala, Wen‐Horng Wang, R. Hullinger, S. Cairo, M. Buendia, O. Andrisani (2009)
Polo‐like kinase 1 inhibition suppresses hepatitis B virus X protein‐induced transformation in an in vitro model of liver cancer progressionHepatology, 50
-
O. Terradillos, O. Billet, C. Renard, R. Levy, T. Molina, P. Briand, M. Buendia (1997)
The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic miceOncogene, 14
-
M. Petronczki, P. Lénárt, J. Peters (2008)
Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.Developmental cell, 14 5
-
C. Boer, J. Krieken, Connie Rhijn, S. Litvinov (1999)
Expression of Ep‐CAM in normal, regenerating, metaplastic, and neoplastic liverThe Journal of Pathology, 188
-
Leo Studach, Wen‐Horng Wang, Gregory Weber, Jiabin Tang, R. Hullinger, Raphael Malbrue, Xiaoqi Liu, O. Andrisani (2010)
Polo-like Kinase 1 Activated by the Hepatitis B Virus X Protein Attenuates Both the DNA Damage Checkpoint and DNA Repair Resulting in Partial Polyploidy*The Journal of Biological Chemistry, 285
-
Sook Lee, C. Tarn, Wen‐Horng Wang, Sigeng Chen, R. Hullinger, O. Andrisani (2002)
Hepatitis B Virus X Protein Differentially Regulates Cell Cycle Progression in X-transforming Versus Nontransforming Hepatocyte (AML12) Cell Lines*The Journal of Biological Chemistry, 277
-
B. Terris, C. Cavard, C. Perret (2010)
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.Journal of hepatology, 52 2
-
O. Andrisani, Leo Studach, P. Merle (2011)
Gene signatures in hepatocellular carcinoma (HCC).Seminars in cancer biology, 21 1
-
J. Simon, R. Kingston (2009)
Mechanisms of Polycomb gene silencing: knowns and unknownsNature Reviews Molecular Cell Biology, 10
-
Chen (2002)
Gene expression patterns in human liver cancersMol Biol Cell, 13
-
Xin Chen, S. Cheung, S. So, S. Fan, Christopher Barry, J. Higgins, K. Lai, J. Ji, S. Dudoit, I. Ng, M. Rijn, D. Botstein, P. Brown (2002)
Gene expression patterns in human liver cancers.Molecular biology of the cell, 13 6
-
A. Bracken, Nikolaj Dietrich, Diego Pasini, K. Hansen, K. Helin (2006)
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.Genes & development, 20 9
-
Jennifer Anderton, S. Bose, M. Vockerodt, K. Vrzalikova, Wenbin Wei, M. Kuo, K. Helin, J. Christensen, M. Rowe, P. Murray, C. Woodman (2011)
The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's LymphomaOncogene, 30
-
K. Breuhahn, S. Vreden, R. Haddad, S. Beckebaum, D. Stippel, P. Flemming, T. Nussbaum, W. Caselmann, B. Haab, P. Schirmacher (2004)
Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II OverexpressionCancer Research, 64
-
Jing Zhao, Toshiro Ohsumi, Johnny Kung, Y. Ogawa, D. Grau, K. Sarma, Ji Song, R. Kingston, M. Borowsky, Jeannie Lee (2010)
Genome-wide identification of polycomb-associated RNAs by RIP-seq.Molecular cell, 40 6
-
Lova Rakotomalala, Leo Studach, Wen‐Horng Wang, G. Grégori, R. Hullinger, O. Andrisani (2008)
Hepatitis B Virus X Protein Increases the Cdt1-to-Geminin Ratio Inducing DNA Re-replication and Polyploidy*Journal of Biological Chemistry, 283
-
J. Jacob, Á. Sterczer, I. Toshkov, A. Yeager, B. Korba, P. Cote, M. Buendia, J. Gerin, B. Tennant (2004)
Integration of woodchuck hepatitis and N‐myc rearrangement determine size and histologic grade of hepatic tumorsHepatology, 39
-
J. Llovet, J. Bruix (2008)
Molecular targeted therapies in hepatocellular carcinomaHepatology, 48
-
Amy Svotelis, Stéphanie Bianco, J. Madore, Gabriel Huppé, Alexei Nordell-Markovits, A. Mes-Masson, N. Gevry (2011)
H3K27 demethylation by JMJD3 at a poised enhancer of anti‐apoptotic gene BCL2 determines ERα ligand dependencyThe EMBO Journal, 30
-
T. Yamashita, Junfang Ji, A. Budhu, M. Forgues, Wen Yang, Hong-Yang Wang, H. Jia, Q. Ye, L. Qin, E. Wauthier, L. Reid, H. Minato, M. Honda, S. Kaneko, Zhao-You Tang, X. Wang (2009)
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.Gastroenterology, 136 3
-
Chian-Feng Chen, S. Yeh, Ding‐Shinn Chen, Pei‐Jer Chen, Y. Jou (2005)
Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11Genes, 44
-
W. McGinnis, C. Hart, W. Gehring, F. Ruddle (1984)
Molecular cloning and chromosome mapping of a mouse DNA sequence homologous to homeotic genes of drosophilaCell, 38
-
P. Cote, B. Korba, Roger Miller, J. Jacob, B. Baldwin, W. Hornbuckle, R. Purcell, B. Tennant, J. Gerin (2000)
Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infectionHepatology, 31
-
Duonan Yu, D. Cozma, A. Park, A. Thomas-Tikhonenko (2005)
Functional Validation of Genes Implicated in Lymphomagenesis: An in Vivo Selection Assay Using a Myc‐Induced B‐Cell TumorAnnals of the New York Academy of Sciences, 1059
-
G. Spinzi, S. Paggi (2008)
Sorafenib in advanced hepatocellular carcinoma.The New England journal of medicine, 359 23
-
C. Gouillat, D. Manganas, F. Zoulim, D. Vitrey, G. Saguier, M. Guillaud, J. Ain, R. Duque-Campos, C. Jamard, M. Praves, C. Trépo (1997)
Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma.Journal of hepatology, 26 6
-
S. Boyault, D. Rickman, A. Reyniès, C. Balabaud, S. Rebouissou, E. Jeannot, A. Hérault, J. Saric, J. Belghiti, D. Franco, P. Bioulac-Sage, P. Laurent-Puig, J. Zucman‐Rossi (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 45
-
Tung‐Ying Lu, R. Lu, Mei-Ying Liao, John Yu, C. Chung, C. Kao, Han‐Chung Wu (2010)
Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells*The Journal of Biological Chemistry, 285
-
S. Menne, P. Cote (2007)
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.World journal of gastroenterology, 13 1
-
Ju-Seog Lee, I. Chu, Jeonghoon Heo, D. Calvisi, Zong-tang Sun, T. Roskams, A. Durnez, A. Demetris, S. Thorgeirsson (2004)
Classification and prediction of survival in hepatocellular carcinoma by gene expression profilingHepatology, 40
-
T. Yamashita, M. Forgues, Wei Wang, J. Kim, Q. Ye, H. Jia, A. Budhu, Krista Zanetti, Yidong Chen, L. Qin, Zhao-You Tang, X. Wang (2008)
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.Cancer research, 68 5
-
Diego Pasini, P. Cloos, J. Walfridsson, L. Olsson, John‐Paul Bukowski, J. Johansen, M. Bak, N. Tommerup, J. Rappsilber, K. Helin (2010)
JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cellsNature, 464
-
B. Tennant, I. Toshkov, S. Peek, J. Jacob, S. Menne, W. Hornbuckle, Raymond Schinazi, B. Korba, P. Cote, J. Gerin (2004)
Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.Gastroenterology, 127 5 Suppl 1
-
Aditi Kanhere, K. Viiri, C. Araújo, J. Rasaiyaah, R. Bouwman, Warren Whyte, C. Pereira, Emily Brookes, Kimberly Walker, G. Bell, A. Pombo, A. Fisher, R. Young, Richard Jenner (2010)
Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2.Molecular cell, 38 5
-
R. Beasley, Chia‐Chin Lin, L. Hwang, C. Chien (1981)
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in TaiwanThe Lancet, 318
-
D. Iliopoulos, Marianne Lindahl-Allen, C. Polytarchou, H. Hirsch, P. Tsichlis, K. Struhl (2010)
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.Molecular cell, 39 5
-
M. Steegmaier, M. Hoffmann, A. Baum, P. Lénárt, M. Petronczki, M. Krššák, U. Gürtler, P. Garin‐Chesa, Simone Lieb, J. Quant, M. Grauert, G. Adolf, N. Kraut, J. Peters, W. Rettig (2007)
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In VivoCurrent Biology, 17
-
F. Zoulim, T. Poynard, F. Degos, A. Slama, A. Hasnaoui, P. Blin, F. Mercier, P. Dény, P. Landais, P. Parvaz, C. Trépo (2006)
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudineJournal of Viral Hepatitis, 13
-
T. Hagen, Shao-Nan Huang, John Curnutte, P. Fowler, Violeta Martinez, C. Wehr, Bruce Ames, F. Chisari (1994)
Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 91 26
-
Wen‐Horng Wang, Leo Studach, O. Andrisani (2011)
Proteins ZNF198 and SUZ12 are down‐regulated in hepatitis B virus (HBV) X protein‐mediated hepatocyte transformation and in HBV replicationHepatology, 53
-
R. Villa, Diego Pasini, A. Gutiérrez, L. Morey, M. Occhionorelli, Emmanuelle Viré, J. Nomdedéu, T. Jenuwein, P. Pelicci, S. Minucci, F. Fuks, K. Helin, L. Croce (2007)
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia.Cancer cell, 11 6
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 2012 American Association for the Study of Liver Diseases
- ISSN
- 0270-9139
- eISSN
- 1527-3350
- DOI
- 10.1002/hep.25781
- pmid
- 22505317
- Publisher site
- See Article on Publisher Site
Abstract
Chronic hepatitis B virus (HBV) infection is a major risk factor for developing liver cancer, and the HBV X protein (pX) has been implicated as a cofactor in hepatocyte transformation. We have shown that HBV replication as well as in vitro transformation by pX are associated with induction of the mitotic polo‐like kinase 1 (Plk1) and down‐regulation of the chromatin remodeling components Suz12 and Znf198. Herein, we demonstrate the same inverse relationship between Plk1 and Suz12/Znf198 in liver tumors from X/c‐myc bitransgenic mice and woodchuck hepatitis virus (WHV)‐infected woodchucks. Employing these animal models and the HBV replicating HepAD38 cells we examined the effect of Suz12/Znf198 down‐regulation on gene expression. Genes analyzed include hepatic cancer stem cell markers BAMBI, DKK1,2, DLK1, EpCAM, MYC, and proliferation genes CCNA1, CCND2, IGFII, MCM4‐6, PLK1, RPA2, and TYMS. Suz12 occupancy at the promoters of BAMBI, CCND2, DKK2, DLK1, EpCAM, and IGFII was demonstrated by chromatin immunoprecipitation in untransformed hepatocytes, but was markedly reduced in pX‐transformed and Suz12 knockdown cells. Accordingly, we refer to these genes as “Suz12 repressed” genes in untransformed hepatocytes. The Suz12 repressed genes and proliferation genes were induced in HBV‐replicating HepAD38 cells and, interestingly, they exhibited distinct expression profiles during hepatocellular carcinoma (HCC) progression in X/c‐myc bitransgenics. Specifically, CCND2, EpCAM, and IGFII expression was elevated at the proliferative and preneoplastic stages in X/c‐myc bitransgenic livers, whereas BAMBI and PLK1 were overexpressed in hepatic tumors from X/c‐myc bitransgenics and WHV‐infected woodchucks. Importantly, most of these genes were selectively up‐regulated in HBV‐induced HCCs. Conclusion: The distinct expression profile of the identified Suz12 repressed genes in combination with the proliferation genes hold promise as biomarkers for progression of chronic HBV infection to HCC. (HEPATOLOGY 2012)
Journal
Hepatology – Wolters Kluwer Health
Published: Oct 1, 2012